WO-2015034031
Mitsubishi Tanabe Pharma Corporation
The present invention provides a novel crystal form of an arylalkylamine compound. Specifically, a novel crystal form of 4-(3S-(1R-(1-naphthyl)ethylamino)pyrrolidin-1- yl)phenylacetic acid has excellent stability, and is therefore useful as an active ingredient for a medicine. The present invention also provides an industrially advantageous method for producing an arylalkylamine compound.
.............
.READ........... http://newdrugapprovals.org/2015/03/16/khk-7580/
http://newdrugapprovals.org/2015/03/16/khk-7580/
